T-Cell Response to TB Infection: High-Resolution Imaging Reveals Major Differences Between Lab and Live Results.
Volunteer for NIAID-funded clinical studies related to tuberculosis on ClinicalTrials.gov.
An ancient disease, TB remains one of the major causes of disability and death worldwide. In 2010, an estimated 8.8 million people fell ill with TB, including 1.1 million cases among people with HIV, according to the World Health Organization. Of the 1.4 million deaths, 95 percent occurred in developing countries. NIAID is part of the global research community that is committed to finding new ways to better understand, diagnose, treat, and ultimately prevent TB. More about NIAID TB Research.
Multidrug-resistant and Extensively Drug-resistant Tuberculosis Research Agenda (PDF)
NIAID Role in Addressing TB, Drug-Resistant TB, and TB in People with HIV/AIDS
NIH Expands Key Tuberculosis Research Program—Feb. 18, 2015
Media Availability: Imaging Techniques Reliably Predict Treatment Outcomes for TB Patients—Dec. 4, 2014
Media Availability: NIH Scientists Establish Proof-of-Concept for Host-Directed Tuberculosis Therapy—June 26, 2014
Bulletin: World TB Day—March 24, 2014
New TB Resource at PATRIC Bioinformatics Resource Center
All TB News Releases
News From NIAID-Supported Institutions
Last Updated February 18, 2015